Adocia S.A.
OTC: ADOIF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Olivier Soula
- Employees
- 97
- Headquarters
- Lyon, France
- IPO year
- 2014
- Market cap
- $103.7M
- Website
- https://www.adocia.com
Loading ADOIF…
Loading profile data…Frequently asked questions about ADOIF
What does Adocia S.A. (ADOIF) do?
Adocia S.A., a biotechnology firm founded in Lyon, France, in 2005, operates at the clinical stage, focusing its research and development efforts on optimizing existing therapeutic proteins and peptides for the management of diabetes and various other metabolic conditions. The company's core innovation lies in its proprietary BioChaperone techno...
Where does ADOIF trade?
Adocia S.A. (ADOIF) trades on the Other OTC.
What sector is ADOIF in?
Adocia S.A. (ADOIF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Adocia S.A.?
Olivier Soula is the chief executive officer of Adocia S.A. (ADOIF).
Where is Adocia S.A. headquartered?
Adocia S.A. is headquartered in France.
Does ADOIF pay a dividend?
Adocia S.A. (ADOIF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ADOIF go public?
Adocia S.A. (ADOIF) completed its initial public offering in 2014.